Bowhead Specialty Holdings (BOW) Cash & Equivalents (2023 - 2026)

Bowhead Specialty Holdings has reported Cash & Equivalents for 4 years, with the latest figure at $97.2 million in Q1 2026.

• Quarterly Cash & Equivalents rose 10.37% year-over-year to $97.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.2 million (up 10.37% YoY) and the FY2025 annual result came in at $40.2 million, down 58.73% from the prior year.
• Cash & Equivalents rose to $97.2 million in Q1 2026 per BOW's latest filing, from $40.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $197.9 million in Q3 2025 and troughed at $1.7 million in Q4 2023.
• A 4-year average of $83.2 million and a median of $80.8 million in 2024 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 5640.64% in 2024, down 74.53% in 2024.
• Over 4 years, Cash & Equivalents stood at $1.7 million in 2023, then surged by 5640.64% to $97.5 million in 2024, then tumbled by 58.73% to $40.2 million in 2025, then soared by 141.6% to $97.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $97.2 million, $40.2 million, and $197.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.